# A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

> **NCT04023903** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Healthy Subject

## Interventions

- **DRUG:** Bardoxolone methyl
- **DRUG:** Bardoxolone methyl

## Key facts

- **NCT ID:** NCT04023903
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-04
- **Primary completion:** 2019-06-14
- **Final completion:** 2019-06-14
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023903, "A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04023903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*